OTCM
BHCCF
Market cap584mUSD
May 24, Last price
0.79USD
Name
Benchmark Holdings PLC
Chart & performance
P/E
—
P/S
4.83
EPS
—
Vol. 1Y
—
Shs. 5Y
5.77%
Rev. 5Y
-6.63%
Div Yld LY
—
Div Yld TTM
—
Revenues
90m
-46.68%
Net income
-39m
L+70.50%
CFO
2m
-89.98%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Benchmark Holdings plc, alongside its various subsidiaries, offers specialized technical services, innovative products, and expert knowledge designed to bolster the progress of food and farming industries worldwide. The company maintains a significant global presence, with operations spanning the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, and other parts of Europe. Benchmark structures its business through three primary segments: Genetics, Advanced Nutrition, and Health. Its Genetics division focuses on providing cutting-edge salmon breeding technologies and production infrastructure to deliver genetically superior ova, primarily for the aquaculture sector. The Advanced Nutrition segment is responsible for manufacturing and distributing crucial nutritional and health-enhancing products tailored specifically for the aquaculture industry. Furthermore, the Health segment supplies a range of dedicated health solutions to the aquatic farming market. Benchmark Holdings plc was established in 2000 and is headquartered in Sheffield, United Kingdom.
Related entities
Subsidiaries (11)
BENCHMARK ANIMAL HEALTH GROUP LIMITED
BENCHMARK ANIMAL HEALTH LIMITED
BENCHMARK GENETICS CHILE SPA
BENCHMARK GENETICS ICELAND HF
BENCHMARK GENETICS LIMITED
BENCHMARK GENETICS NORWAY AS
BENCHMARK HOLDING EUROPE B.V.
INVE AQUACULTURE TEMP HOLDING B.V.
INVE ASIA LIMITED
Inve Technologies
INVE USA HOLDINGS, INC.
Key people
James Banfield
Head of Technical Publishing, Managing Director - 5M Publishing
Roland Bonney
Chief Operating Officer, Executive Director
Director of Investor Relations · since 2017
Pierre Hugo
Finance Director of INVE
Jan-Emil Johannessen
Managing Director of SalmoBreed
Patrick Lavens
Innovations Director of INVE
Ruth Layton
Benchmark Co-founder, Head of Benchmark Sustainability Science · since 2017
Philippe Leger
Chief Executive Officer of INVE
Stelios Leontios
Commercial Director of INVE
Bob Long
Managing Director of Benchmark Vaccines ltd
John Marshall
Technical Director of FVG & BVL
Morten Rye
Managing Director of Akvaforsk Genetics
Athene Blakeman
Company Secretary, Group Legal Counsel · since 2014
Peter Lutz George
Executive Chairman of the Board · since 2019
Malcolm Pye
Non-Executive Director · since 2019
Senior Non-Executive Independent Director · since 2017
Legal address
HIGHDOWN HOUSE
YEOMAN WAY
WORTHING, WSX BN99 3HH
GB
YEOMAN WAY
WORTHING, WSX BN99 3HH
GB
Headquarters
4 PARK SQUARE, THORNCLIFFE PARK, CHAPELTOWN
SHEFFIELD, SHF S35 2PH
GB
SHEFFIELD, SHF S35 2PH
GB
Previous name
BENCHMARK HOLDINGS PLC
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||